Targeted drug delivery systems for pancreatic ductal adenocarcinoma: overcoming tumor microenvironment challenges with CAF-specific nanoparticles

Ho, 2020, The tumour microenvironment in pancreatic cancer – clinical challenges and opportunities, Nat Rev Clin Oncol, 17, 527, 10.1038/s41571-020-0363-5 Wang, 2021, Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration, J Control Release, 331, 282, 10.1016/j.jconrel.2020.08.045 Lavie, 2022, Cancer-associated fibroblasts in the single-cell era, Nat Cancer, 3, 793, 10.1038/s43018-022-00411-z Yuan, 2023, Transforming cancer-associated fibroblast barrier into drug depots to boost chemo-immunotherapy in “shooting fish in a barrel” pattern, ACS Nano Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat Biotechnol, 33, 941, 10.1038/nbt.3330 Jin, 2023, Rational combinations of targeted cancer therapies: background, advances and challenges, Nat Rev Drug Discov, 22, 213, 10.1038/s41573-022-00615-z Liao, 2014, A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin, J Am Chem Soc, 136, 5896, 10.1021/ja502011g Wang, 2021, Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration, J Control Release, 331, 282, 10.1016/j.jconrel.2020.08.045 Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat Rev Cancer, 17, 20, 10.1038/nrc.2016.108 Li, 2022, Clinical translation of long-acting drug delivery formulations, Nat Rev Mater, 7, 406, 10.1038/s41578-021-00405-w